XERS Competitors & Alternatives

Compare Xeris Pharmaceuticals Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

XERS

Main Stock
$8.16
Tradestie Score
59
Market Cap
$1.29B
P/E Ratio
115.4
Revenue Growth
0.4%
Analyst Upside
+38.4%

Top Competitors

45 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
PAHC Phibro Animal Health Corporation Class A
$36.58
$1.65B 15.6 50 Compare
BCRX BioCryst Pharmaceuticals Inc
$8.91
$1.55B - 50 Compare
AMLX Amylyx Pharmaceuticals, Inc. Common Stock
$21.87
$1.49B - 59 Compare
AVDL Avadel Pharmaceuticals plc Ordinary Share
$21.64
$1.46B - 62 Compare
EVO Evotec SE American Depositary Shares
$1.95
$1.34B - 52 Compare
ARDX Ardelyx, Inc.
$4.99
$1.29B - 60 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$20.12
$1.25B 12.0 53 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 55 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$27.10
$1.14B 203.2 53 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$35.60
$1.11B 17.2 55 Compare

Data updated: Aug 04, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

45 stocks in this industry